{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:10Z","timestamp":1787003830591,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-159923"],"award-info":[{"award-number":["FDN-159923"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["PT 103179"],"award-info":[{"award-number":["PT 103179"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Richard and Edith Strauss Foundation"},{"DOI":"10.13039\/501100000156","name":"FRQ | Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Cedars Cancer Foundation"},{"name":"Genome Quebec"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Natural killer (NK) cells are promising candidates for allogeneic anti-cancer immunotherapy. However, their cytolytic activity is often suppressed by the tumor microenvironment. We demonstrate that genetic silencing or pharmacological dual inhibition of protein tyrosine phosphatases PTPN1 and PTPN2 (PTPN1\/N2) in NK cells significantly enhances anti-tumor cytolytic activity both in vitro and in vivo. This augmented NK cell activity is mediated by increased expression of early activation markers and the production of effector molecules such as granzyme B and interferon-gamma (IFN-\u03b3). Notably, this elevated cell cytolytic response remains substantially resistant to the immunosuppressive effects of TGF\u03b2-1, a cytokine known to dampen NK cell activity and commonly present in the tumor microenvironment. Mechanistically, targeting PTPN1\/N2 in NK cells promotes JAK\/STAT signaling pathways and sensitizes cells to IL-2 stimulation. Importantly, dual inhibition of PTPN1\/N2 markedly enhances the cytolytic activity of cord blood NK cells against patient-derived glioblastoma cells, highlighting the potential of this approach for future therapeutic applications. These findings provide compelling evidence that dual targeting of PTPN1\/N2 could significantly improve the efficacy of therapeutic\n                    <jats:italic>\u201coff-the-shelf<\/jats:italic>\n                    \u201d NK cell-based immunotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s44319-026-00745-0","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:03:08Z","timestamp":1776243788000},"page":"2581-2613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PTPN1\/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGF\u03b21 responses"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-8831","authenticated-orcid":false,"given":"Chu-Han","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-2956","authenticated-orcid":false,"given":"Linda","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffanie","family":"Chouleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1753-1940","authenticated-orcid":false,"given":"Milea","family":"DiPonzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre J","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzet M","family":"Cordova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-6111","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Tabari\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-5229","authenticated-orcid":false,"given":"Andreas","family":"Bikfalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5568-6586","authenticated-orcid":false,"given":"Peter M","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Laneuville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0281-541X","authenticated-orcid":false,"given":"Michel L","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1021\/acsmedchemlett.1c00678","volume":"13","author":"AF Abdel-Magid","year":"2022","unstructured":"Abdel-Magid AF (2022) The inhibitors of protein tyrosine phosphatase nonreceptor type 2 (PTPN2) as potential enhancers of cancer immunotherapy and type 1 (PTPN1) as treatment of metabolic diseases. ACS Med Chem Lett 13:19\u201321","journal-title":"ACS Med Chem Lett"},{"key":"745_CR2","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","volume":"9","author":"AM Abel","year":"2018","unstructured":"Abel AM, Yang C, Thakar MS, Malarkannan S (2018) Natural killer cells: development, maturation, and clinical utilization. Front Immunol 9:1869","journal-title":"Front Immunol"},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1126\/science.8128219","volume":"263","author":"D Barford","year":"1994","unstructured":"Barford D, Flint AJ, Tonks NK (1994) Crystal structure of human protein tyrosine phosphatase 1B. Science 263:1397\u20131404","journal-title":"Science"},{"key":"745_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2008.11.038","volume":"136","author":"AJ Barr","year":"2009","unstructured":"Barr AJ, Ugochukwu E, Lee WH, King ON, Filippakopoulos P, Alfano I, Savitsky P, Burgess-Brown NA, Muller S, Knapp S (2009) Large-scale structural analysis of the classical human protein tyrosine phosphatome. Cell 136:352\u2013363","journal-title":"Cell"},{"key":"745_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41586-023-06575-7","volume":"622","author":"CK Baumgartner","year":"2023","unstructured":"Baumgartner CK, Ebrahimi-Nik H, Iracheta-Vellve A, Hamel KM, Olander KE, Davis TGR, McGuire KA, Halvorsen GT, Avila OI, Patel CH et al (2023) The PTPN2\/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity. Nature 622:850\u2013862","journal-title":"Nature"},{"key":"745_CR7","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.4049\/jimmunol.0903354","volume":"185","author":"J Brady","year":"2010","unstructured":"Brady J, Carotta S, Thong RP, Chan CJ, Hayakawa Y, Smyth MJ, Nutt SL (2010) The interactions of multiple cytokines control NK cell maturation. J Immunol 185:6679\u20136688","journal-title":"J Immunol"},{"key":"745_CR8","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.celrep.2016.04.053","volume":"15","author":"GW Chang","year":"2016","unstructured":"Chang GW, Hsiao CC, Peng YM, Vieira Braga FA, Kragten NA, Remmerswaal EB, van de Garde MD, Straussberg R, Konig GM, Kostenis E et al (2016) The adhesion G protein-coupled receptor GPR56\/ADGRG1 is an inhibitory receptor on human NK cells. Cell Rep 15:1757\u20131770","journal-title":"Cell Rep"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","volume":"9","author":"S Chen","year":"2024","unstructured":"Chen S, Zhu H, Jounaidi Y (2024) Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. Signal Transduct Target Ther 9:302","journal-title":"Signal Transduct Target Ther"},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1172\/JCI71668","volume":"124","author":"X Chen","year":"2014","unstructured":"Chen X, Wang H, Liao HJ, Hu W, Gewin L, Mernaugh G, Zhang S, Zhang ZY, Vega-Montoto L, Vanacore RM et al (2014) Integrin-mediated type II TGF-beta receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling. J Clin Invest 124:3295\u20133310","journal-title":"J Clin Invest"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1073\/pnas.1221312110","volume":"110","author":"PJ Choi","year":"2013","unstructured":"Choi PJ, Mitchison TJ (2013) Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells. Proc Natl Acad Sci USA 110:6488\u20136493","journal-title":"Proc Natl Acad Sci USA"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"e003894","DOI":"10.1136\/jitc-2021-003894","volume":"9","author":"I Christodoulou","year":"2021","unstructured":"Christodoulou I, Ho WJ, Marple A, Ravich JW, Tam A, Rahnama R, Fearnow A, Rietberg C, Yanik S, Solomou EE et al (2021) Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities. J Immunother Cancer 9:e003894","journal-title":"J Immunother Cancer"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/labinvest.3700720","volume":"88","author":"GP Christophi","year":"2008","unstructured":"Christophi GP, Hudson CA, Gruber RC, Christophi CP, Mihai C, Mejico LJ, Jubelt B, Massa PT (2008) SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest 88:243\u2013255","journal-title":"Lab Invest"},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","volume":"97","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97:3146\u20133151","journal-title":"Blood"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","volume":"49","author":"A Crinier","year":"2018","unstructured":"Crinier A, Milpied P, Escaliere B, Piperoglou C, Galluso J, Balsamo A, Spinelli L, Cervera-Marzal I, Ebbo M, Girard-Madoux M et al (2018) High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice. Immunity 49:971\u2013986.e975","journal-title":"Immunity"},{"key":"745_CR16","first-page":"vdz029","volume":"1","author":"T Daubon","year":"2019","unstructured":"Daubon T, Guyon J, Raymond AA, Dartigues B, Rudewicz J, Ezzoukhry Z, Dupuy JW, Herbert JMJ, Saltel F, Bjerkvig R et al (2019) The invasive proteome of glioblastoma revealed by laser-capture microdissection. Neurooncol Adv 1:vdz029","journal-title":"Neurooncol Adv"},{"key":"745_CR3","unstructured":"Deb A, Nebelitsky E, Slepushkin V (2017) Buffers for stabilization of lentiviral preparations. International Publication No. WO 2017\/087861"},{"key":"745_CR17","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1016\/j.celrep.2019.08.019","volume":"28","author":"GT Dodd","year":"2019","unstructured":"Dodd GT, Xirouchaki CE, Eramo M, Mitchell CA, Andrews ZB, Henry BA, Cowley MA, Tiganis T (2019) Intranasal targeting of hypothalamic PTP1B and TCPTP reinstates leptin and insulin sensitivity and promotes weight loss in obesity. Cell Rep 28:2905\u20132922.e2905","journal-title":"Cell Rep"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1600-065X.2008.00743.x","volume":"228","author":"KM Doody","year":"2009","unstructured":"Doody KM, Bourdeau A, Tremblay ML (2009) T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunol Rev 228:325\u2013341","journal-title":"Immunol Rev"},{"key":"745_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4161\/cc.3.5.851","volume":"3","author":"N Dube","year":"2004","unstructured":"Dube N, Tremblay ML (2004) Beyond the metabolic function of PTP1B. Cell Cycle 3:550\u2013553","journal-title":"Cell Cycle"},{"key":"745_CR20","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","volume":"283","author":"M Elchebly","year":"1999","unstructured":"Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC et al (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544\u20131548","journal-title":"Science"},{"key":"745_CR21","doi-asserted-by":"crossref","unstructured":"Felices M, Lenvik AJ, McElmurry R, Chu S, Hinderlie P, Bendzick L, Geller MA, Tolar J, Blazar BR, Miller JS (2018) Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect. JCI Insight 3:e96219","DOI":"10.1172\/jci.insight.96219"},{"key":"745_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-022-02542-8","volume":"41","author":"K Fooks","year":"2022","unstructured":"Fooks K, Galicia-Vazquez G, Gife V, Schcolnik-Cabrera A, Nouhi Z, Poon WWL, Luo V, Rys RN, Aloyz R, Orthwein A et al (2022) EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax. J Exp Clin Cancer Res 41:340","journal-title":"J Exp Clin Cancer Res"},{"key":"745_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","volume":"47","author":"AG Freud","year":"2017","unstructured":"Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA (2017) The broad spectrum of human natural killer cell diversity. Immunity 47:820\u2013833","journal-title":"Immunity"},{"key":"745_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1810804","volume":"2022","author":"S Gonzalez-Ochoa","year":"2022","unstructured":"Gonzalez-Ochoa S, Tellez-Banuelos MC, Mendez-Clemente AS, Bravo-Cuellar A, Hernandez Flores G, Palafox-Mariscal LA, Haramati J, Pedraza-Brindis EJ, Sanchez-Reyes K, Ortiz-Lazareno PC (2022) Combination blockade of the IL6R\/STAT-3 axis with TIGIT and its impact on the functional activity of NK cells against prostate cancer cells. J Immunol Res 2022:1810804","journal-title":"J Immunol Res"},{"key":"745_CR25","first-page":"694","volume":"7","author":"D Gotthardt","year":"2016","unstructured":"Gotthardt D, Sexl V (2016) STATs in NK-cells: the good, the bad, and the ugly. Front Immunol 7:694","journal-title":"Front Immunol"},{"key":"745_CR26","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.3389\/fimmu.2019.02590","volume":"10","author":"D Gotthardt","year":"2019","unstructured":"Gotthardt D, Trifinopoulos J, Sexl V, Putz EM (2019) JAK\/STAT cytokine signaling at the crossroad of NK cell development and maturation. Front Immunol 10:2590","journal-title":"Front Immunol"},{"key":"745_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2008.302","volume":"19","author":"X Guo","year":"2009","unstructured":"Guo X, Wang X-F (2009) Signaling cross-talk between TGF-\u03b2\/BMP and other pathways. Cell Res 19:71\u201388","journal-title":"Cell Res"},{"key":"745_CR28","doi-asserted-by":"publisher","first-page":"9368","DOI":"10.1073\/pnas.0812109106","volume":"106","author":"KM Heinonen","year":"2009","unstructured":"Heinonen KM, Bourdeau A, Doody KM, Tremblay ML (2009) Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-gamma signaling. Proc Natl Acad Sci USA 106:9368\u20139372","journal-title":"Proc Natl Acad Sci USA"},{"key":"745_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ijc.2910160204","volume":"16","author":"RB Herberman","year":"1975","unstructured":"Herberman RB, Nunn ME, Lavrin DH (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216\u2013229","journal-title":"Int J Cancer"},{"key":"745_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e41836","volume":"11","author":"KH Hoang Nguyen","year":"2025","unstructured":"Hoang Nguyen KH, Le NV, Nguyen PH, Nguyen HHT, Hoang DM, Huynh CD (2025) Human immune system: exploring diversity across individuals and populations. Heliyon 11:e41836","journal-title":"Heliyon"},{"key":"745_CR31","doi-asserted-by":"publisher","first-page":"208ra145","DOI":"10.1126\/scitranslmed.3006702","volume":"5","author":"A Horowitz","year":"2013","unstructured":"Horowitz A, Strauss-Albee DM, Leipold M, Kubo J, Nemat-Gorgani N, Dogan OC, Dekker CL, Mackey S, Maecker H, Swan GE et al (2013) Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med 5:208ra145","journal-title":"Sci Transl Med"},{"key":"745_CR32","doi-asserted-by":"publisher","first-page":"19982","DOI":"10.1074\/jbc.M200567200","volume":"277","author":"LF Iversen","year":"2002","unstructured":"Iversen LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, Branner S, Mortensen SB, Moller NP (2002) Structure determination of T cell protein-tyrosine phosphatase. J Biol Chem 277:19982\u201319990","journal-title":"J Biol Chem"},{"key":"745_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1371\/journal.pgen.0010027","volume":"1","author":"J Kelley","year":"2005","unstructured":"Kelley J, Walter L, Trowsdale J (2005) Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet 1:129\u2013139","journal-title":"PLoS Genet"},{"key":"745_CR34","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1182\/blood.2022018079","volume":"140","author":"S Kim","year":"2022","unstructured":"Kim S, Choi J (2022) Restoring NK cell functions in AML relapse. Blood 140:2765\u20132766","journal-title":"Blood"},{"key":"745_CR35","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1128\/MCB.20.15.5479-5489.2000","volume":"20","author":"LD Klaman","year":"2000","unstructured":"Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH et al (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479\u20135489","journal-title":"Mol Cell Biol"},{"key":"745_CR36","doi-asserted-by":"crossref","unstructured":"Lanier LL (2024) Five decades of natural killer cell discovery. J Exp Med 221:e20231222","DOI":"10.1084\/jem.20231222"},{"key":"745_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","volume":"22","author":"TJ Laskowski","year":"2022","unstructured":"Laskowski TJ, Biederstadt A, Rezvani K (2022) Natural killer cells in antitumour adoptive cell immunotherapy. Nat Rev Cancer 22:557\u2013575","journal-title":"Nat Rev Cancer"},{"key":"745_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mehy.2010.10.027","volume":"76","author":"P Li","year":"2011","unstructured":"Li P, Katirai F, Zheng F, Gong F (2011) Recycling and reutilization of cytotoxic molecules, a new type of energy conservation of NK cells?. Med Hypotheses 76:293\u2013295","journal-title":"Med Hypotheses"},{"key":"745_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, Chen Y (2022) Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol 15:121","journal-title":"J Hematol Oncol"},{"key":"745_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40170-8","volume":"14","author":"S Liang","year":"2023","unstructured":"Liang S, Tran E, Du X, Dong J, Sudholz H, Chen H, Qu Z, Huntington ND, Babon JJ, Kershaw NJ et al (2023) A small molecule inhibitor of PTP1B and PTPN2 enhances T cell anti-tumor immunity. Nat Commun 14:4524","journal-title":"Nat Commun"},{"key":"745_CR41","doi-asserted-by":"crossref","unstructured":"Liu R, Mathieu C, Berthelet J, Zhang W, Dupret JM, Rodrigues Lima F (2022) Human protein tyrosine phosphatase 1B (PTP1B): from structure to clinical inhibitor perspectives. Int J Mol Sci 23:7027","DOI":"10.3390\/ijms23137027"},{"key":"745_CR42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cmet.2011.09.011","volume":"14","author":"K Loh","year":"2011","unstructured":"Loh K, Fukushima A, Zhang X, Galic S, Briggs D, Enriori PJ, Simonds S, Wiede F, Reichenbach A, Hauser C et al (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14:684\u2013699","journal-title":"Cell Metab"},{"key":"745_CR43","doi-asserted-by":"crossref","unstructured":"Luo K (2017) Signaling cross talk between TGF-\u03b2\/smad and other signaling pathways. Cold Spring Harb Perspect Biol 9:a022137","DOI":"10.1101\/cshperspect.a022137"},{"key":"745_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/icb.2013.96","volume":"92","author":"EM Mace","year":"2014","unstructured":"Mace EM, Dongre P, Hsu HT, Sinha P, James AM, Mann SS, Forbes LR, Watkin LB, Orange JS (2014) Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol Cell Biol 92:245\u2013255","journal-title":"Immunol Cell Biol"},{"key":"745_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23270","volume":"547","author":"RT Manguso","year":"2017","unstructured":"Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC, Collins NB, Bi K, LaFleur MW, Juneja VR et al (2017) In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature 547:413\u2013418","journal-title":"Nature"},{"key":"745_CR46","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","volume":"30","author":"D Marin","year":"2024","unstructured":"Marin D, Li Y, Basar R, Rafei H, Daher M, Dou J, Mohanty V, Dede M, Nieto Y, Uprety N et al (2024) Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) B cell tumors: a phase 1\/2 trial. Nat Med 30:772\u2013784","journal-title":"Nat Med"},{"key":"745_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211069012","volume":"10","author":"B Mirlekar","year":"2022","unstructured":"Mirlekar B (2022) Tumor promoting roles of IL-10, TGF-beta, IL-4, and IL-35: its implications in cancer immunotherapy. SAGE Open Med 10:20503121211069012","journal-title":"SAGE Open Med"},{"key":"745_CR49","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1074\/jbc.M511546200","volume":"281","author":"J Montalibet","year":"2006","unstructured":"Montalibet J, Skorey K, McKay D, Scapin G, Asante-Appiah E, Kennedy BP (2006) Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding. J Biol Chem 281:5258\u20135266","journal-title":"J Biol Chem"},{"key":"745_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1465-9921-8-62","volume":"8","author":"MC Morissette","year":"2007","unstructured":"Morissette MC, Parent J, Milot J (2007) Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema. Respir Res 8:62","journal-title":"Respir Res"},{"key":"745_CR51","doi-asserted-by":"publisher","first-page":"47771","DOI":"10.1074\/jbc.C100583200","volume":"276","author":"MP Myers","year":"2001","unstructured":"Myers MP, Andersen JN, Cheng A, Tremblay ML, Horvath CM, Parisien JP, Salmeen A, Barford D, Tonks NK (2001) TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem 276:47771\u201347774","journal-title":"J Biol Chem"},{"key":"745_CR52","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.jcyt.2019.03.420","volume":"21","author":"W Ng","year":"2019","unstructured":"Ng W, Tam D, Liao D, Lee W, Chan F (2019) Ultrastructure of cytokine induced human natural killer cells. Cytotherapy 21:S52\u2013S53","journal-title":"Cytotherapy"},{"key":"745_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fimmu.2016.00101","volume":"7","author":"CM Nielsen","year":"2016","unstructured":"Nielsen CM, Wolf AS, Goodier MR, Riley EM (2016) Synergy between common \u03b3 chain family cytokines and IL-18 potentiates innate and adaptive pathways of NK cell activation. Front Immunol 7:101","journal-title":"Front Immunol"},{"key":"745_CR54","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.4049\/jimmunol.156.12.4531","volume":"156","author":"L Olcese","year":"1996","unstructured":"Olcese L, Lang P, Vely F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L et al (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol 156:4531\u20134534","journal-title":"J Immunol"},{"key":"745_CR55","doi-asserted-by":"publisher","first-page":"15263","DOI":"10.1074\/jbc.M111.303958","volume":"287","author":"C Ortiz","year":"2012","unstructured":"Ortiz C, Caja L, Bertran E, Gonzalez-Rodriguez A, Valverde AM, Fabregat I, Sancho P (2012) Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-beta (TGF-beta)-induced suppressor effects in hepatocytes. J Biol Chem 287:15263\u201315274","journal-title":"J Biol Chem"},{"key":"745_CR56","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.1074\/jbc.M309979200","volume":"279","author":"A O\u2019Sullivan","year":"2004","unstructured":"O\u2019Sullivan A, Chang HC, Yu Q, Kaplan MH (2004) STAT4 is required for interleukin-12-induced chromatin remodeling of the CD25 locus. J Biol Chem 279:7339\u20137345","journal-title":"J Biol Chem"},{"key":"745_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1321185","volume":"6","author":"C Penafuerte","year":"2017","unstructured":"Penafuerte C, Feldhammer M, Mills JR, Vinette V, Pike KA, Hall A, Migon E, Karsenty G, Pelletier J, Zogopoulos G et al (2017) Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12\/IFN\u03b3 signaling. Oncoimmunology 6:e1321185","journal-title":"Oncoimmunology"},{"key":"745_CR58","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","volume":"10","author":"D Pende","year":"2019","unstructured":"Pende D, Falco M, Vitale M, Cantoni C, Vitale C, Munari E, Bertaina A, Moretta F, Del Zotto G, Pietra G et al (2019) Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation. Front Immunol 10:1179","journal-title":"Front Immunol"},{"key":"745_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113610","volume":"28","author":"LA Perez-Quintero","year":"2025","unstructured":"Perez-Quintero LA, Poirier AJ, Feng CH, Martinez-Cordova Z, Aubry I, Carli C, Kamyabiazar S, Pacis A, Zolotarov Y, Pike KA et al (2025) Uncovering the individual immunotherapeutic roles of PTPN1 and PTPN2 in T cells during dual inhibition. iScience 28:113610","journal-title":"iScience"},{"key":"745_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61196-0","volume":"16","author":"V Picant","year":"2025","unstructured":"Picant V, Revol-Bauz L, Tonon L, Casini T, Voissiere A, Poujol D, Picard E, Rodriguez C, Degletagne C, Sible E et al (2025) Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features. Nat Commun 16:6135","journal-title":"Nat Commun"},{"key":"745_CR61","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cyto.2015.12.025","volume":"82","author":"KA Pike","year":"2016","unstructured":"Pike KA, Tremblay ML (2016) TC-PTP and PTP1B: regulating JAK-STAT signaling, controlling lymphoid malignancies. Cytokine 82:52\u201357","journal-title":"Cytokine"},{"key":"745_CR62","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","volume":"105","author":"I Prager","year":"2019","unstructured":"Prager I, Watzl C (2019) Mechanisms of natural killer cell-mediated cellular cytotoxicity. J Leukoc Biol 105:1319\u20131329","journal-title":"J Leukoc Biol"},{"key":"745_CR63","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.4049\/jimmunol.0900088","volume":"183","author":"AK Purdy","year":"2009","unstructured":"Purdy AK, Campbell KS (2009) SHP-2 expression negatively regulates NK cell function. J Immunol 183:7234\u20137243","journal-title":"J Immunol"},{"key":"745_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104539","volume":"90","author":"ME Raeber","year":"2023","unstructured":"Raeber ME, Sahin D, Karakus U, Boyman O (2023) A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases. EBioMedicine 90:104539","journal-title":"EBioMedicine"},{"key":"745_CR65","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00262-022-03217-1","volume":"71","author":"S Rahmani","year":"2022","unstructured":"Rahmani S, Yazdanpanah N, Rezaei N (2022) Natural killer cells and acute myeloid leukemia: promises and challenges. Cancer Immunol Immunother 71:2849\u20132867","journal-title":"Cancer Immunol Immunother"},{"key":"745_CR66","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.ajpath.2010.12.020","volume":"178","author":"J Revuelta-Cervantes","year":"2011","unstructured":"Revuelta-Cervantes J, Mayoral R, Miranda S, Gonzalez-Rodriguez A, Fernandez M, Martin-Sanz P, Valverde AM (2011) Protein Tyrosine Phosphatase 1B (PTP1B) deficiency accelerates hepatic regeneration in mice. Am J Pathol 178:1591\u20131604","journal-title":"Am J Pathol"},{"key":"745_CR67","doi-asserted-by":"crossref","unstructured":"Robert F, Roman W, Bramoulle A, Fellmann C, Roulston A, Shustik C, Porco JA Jr, Shore GC, Sebag M, Pelletier J (2014) Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma. Proc Natl Acad Sci USA 111:13421\u201313426","DOI":"10.1073\/pnas.1402650111"},{"key":"745_CR68","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F et al (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097\u20132100","journal-title":"Science"},{"key":"745_CR69","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0960-9822(02)00697-8","volume":"12","author":"PD Simoncic","year":"2002","unstructured":"Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ (2002) The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol 12:446\u2013453","journal-title":"Curr Biol"},{"key":"745_CR70","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1139\/y06-012","volume":"84","author":"PD Simoncic","year":"2006","unstructured":"Simoncic PD, McGlade CJ, Tremblay ML (2006) PTP1B and TC-PTP: novel roles in immune-cell signaling. Can J Physiol Pharm 84:667\u2013675","journal-title":"Can J Physiol Pharm"},{"key":"745_CR71","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/bloodadvances.2019000699","volume":"4","author":"SL Smith","year":"2020","unstructured":"Smith SL, Kennedy PR, Stacey KB, Worboys JD, Yarwood A, Seo S, Solloa EH, Mistretta B, Chatterjee SS, Gunaratne P et al (2020) Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing. Blood Adv 4:1388\u20131406","journal-title":"Blood Adv"},{"key":"745_CR72","doi-asserted-by":"crossref","unstructured":"Subedi N, Verhagen LP, de Jonge P, Van Eyndhoven LC, van Turnhout MC, Koomen V, Baudry J, Eyer K, Dolstra H, Tel J (2022) Single-cell profiling reveals functional heterogeneity and serial killing in human peripheral and ex vivo-generated CD34+ progenitor-derived natural killer cells. Adv Biol:e2200207","DOI":"10.1101\/2022.01.24.477494"},{"key":"745_CR73","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1089\/hum.2012.080","volume":"23","author":"T Sutlu","year":"2012","unstructured":"Sutlu T, Nystr\u00f6m S, Gilljam M, Stellan B, Applequist SE, Alici E (2012) Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy. Hum Gene Ther 23:1090\u20131100","journal-title":"Hum Gene Ther"},{"key":"745_CR74","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1101\/gad.319194.118","volume":"33","author":"S Tabari\u00e8s","year":"2019","unstructured":"Tabari\u00e8s S, McNulty A, Ouellet V, Annis MG, Dessureault M, Vinette M, Hachem Y, Lavoie B, Omeroglu A, Simon HG et al (2019) Afadin cooperates with Claudin-2 to promote breast cancer metastasis. Genes Dev 33:180\u2013193","journal-title":"Genes Dev"},{"key":"745_CR75","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/sj.bmt.1703270","volume":"28","author":"K Theilgaard-Monch","year":"2001","unstructured":"Theilgaard-Monch K, Raaschou-Jensen K, Palm H, Schjodt K, Heilmann C, Vindelov L, Jacobsen N, Dickmeiss E (2001) Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transpl 28:1073\u20131082","journal-title":"Bone Marrow Transpl"},{"key":"745_CR47","unstructured":"Therien M, Leblanc Y, Han Y (2013) Fused aromatic phosphonate derivatives as precursors to PTP-1B inhibitors. International Publication No. WO 2013\/155600"},{"key":"745_CR76","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","volume":"280","author":"T Tiganis","year":"2013","unstructured":"Tiganis T (2013) PTP1B and TCPTP-nonredundant phosphatases in insulin signaling and glucose homeostasis. FEBS J 280:445\u2013458","journal-title":"FEBS J"},{"key":"745_CR77","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1128\/MCB.18.3.1622","volume":"18","author":"T Tiganis","year":"1998","unstructured":"Tiganis T, Bennett AM, Ravichandran KS, Tonks NK (1998) Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 18:1622\u20131634","journal-title":"Mol Cell Biol"},{"key":"745_CR78","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1002\/jmv.27849","volume":"94","author":"MK Vakil","year":"2022","unstructured":"Vakil MK, Mansoori Y, Al-Awsi GRL, Hosseinipour A, Ahsant S, Ahmadi S, Ekrahi M, Montaseri Z, Pezeshki B, Mohaghegh P et al (2022) Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll-like receptors dictates pathophysiology of COVID-19 disease. J Med Virol 94:4088\u20134096","journal-title":"J Med Virol"},{"key":"745_CR79","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","volume":"626","author":"E Vivier","year":"2024","unstructured":"Vivier E, Rebuffet L, Narni-Mancinelli E, Cornen S, Igarashi RY, Fantin VR (2024) Natural killer cell therapies. Nature 626:727\u2013736","journal-title":"Nature"},{"key":"745_CR80","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1182\/blood.V95.10.3183","volume":"95","author":"KS Wang","year":"2000","unstructured":"Wang KS, Frank DA, Ritz J (2000) Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 95:3183\u20133190","journal-title":"Blood"},{"key":"745_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.947568","volume":"13","author":"A Witalisz-Siepracka","year":"2022","unstructured":"Witalisz-Siepracka A, Klein K, Zdarsky B, Stoiber D (2022) The multifaceted role of STAT3 in NK-cell tumor surveillance. Front Immunol 13:947568","journal-title":"Front Immunol"},{"key":"745_CR82","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fimmu.2017.00930","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu Y, Tian Z, Wei H (2017) Developmental and functional control of natural killer cells by cytokines. Front Immunol 8:930","journal-title":"Front Immunol"},{"key":"745_CR83","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13045-020-00996-x","volume":"13","author":"J Xu","year":"2020","unstructured":"Xu J, Niu T (2020) Natural killer cell-based immunotherapy for acute myeloid leukemia. J Hematol Oncol 13:167","journal-title":"J Hematol Oncol"},{"key":"745_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11947-7","volume":"10","author":"C Yang","year":"2019","unstructured":"Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS et al (2019) Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome. Nat Commun 10:3931","journal-title":"Nat Commun"},{"key":"745_CR85","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1084\/jem.186.5.683","volume":"186","author":"KE You-Ten","year":"1997","unstructured":"You-Ten KE, Muise ES, Itie A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, Tremblay ML (1997) Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186:683\u2013693","journal-title":"J Exp Med"},{"key":"745_CR86","doi-asserted-by":"crossref","unstructured":"Yu J, Wei M, Becknell B, Trotta R, Liu S, Boyd Z, Jaung MS, Blaser BW, Sun J, Benson DM Jr et al (2006) Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 24:575\u2013590","DOI":"10.1016\/j.immuni.2006.03.016"},{"key":"745_CR87","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.4049\/jimmunol.168.10.5047","volume":"168","author":"S Yusa","year":"2002","unstructured":"Yusa S, Catina TL, Campbell KS (2002) SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol 168:5047\u20135057","journal-title":"J Immunol"},{"key":"745_CR88","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.intimp.2008.03.001","volume":"8","author":"B Zhang","year":"2008","unstructured":"Zhang B, Zhang J, Tian Z (2008) Comparison in the effects of IL-2, IL-12, IL-15 and IFNalpha on gene regulation of granzymes of human NK cell line NK-92. Int Immunopharmacol 8:989\u2013996","journal-title":"Int Immunopharmacol"},{"key":"745_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584099","volume":"11","author":"X Zhao","year":"2020","unstructured":"Zhao X, Cai L, Hu Y, Wang H (2020) Cord-blood natural killer cell-based immunotherapy for cancer. Front Immunol 11:584099","journal-title":"Front Immunol"},{"key":"745_CR90","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/biof.107","volume":"36","author":"NW Zwirner","year":"2010","unstructured":"Zwirner NW, Domaica CI (2010) Cytokine regulation of natural killer cell effector functions. Biofactors 36:274\u2013288","journal-title":"Biofactors"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00745-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-026-00745-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-026-00745-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:32:37Z","timestamp":1779949957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-026-00745-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":90,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5,28]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1038\/s44319-026-00745-0","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Michel L. Tremblay is a founder of Kanyr Pharma Inc., a company developing small-molecule inhibitors of protein tyrosine phosphatases.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}